You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemotherapy naïve

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Biliary Tract Tumors Trial in Seoul (Durvalumab, Tremelimumab, Gemcitabine)

Active, not recruiting
  • Biliary Tract Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 26, 2021

NSCLC Stage IV Trial in Spain (Atezolizumab)

Completed
  • Non-small Cell Lung Cancer Stage IV
  • Elche, Alicante, Spain
  • +14 more
Jan 26, 2023

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)

Completed
  • Carcinoma, Hepatocellular
  • Hepatoma
  • Seongnam, Korea, Republic of
  • +2 more
Dec 4, 2022

NSCLC Trial in China (Atezolizumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer
  • Beijing City, China
  • +20 more
Aug 5, 2022

NSCLC Trial in China (Atezolizumab, Placebo, Bevacizumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Beijing City, China
  • +22 more
Dec 7, 2022

Locally Advanced or Metastatic Pancreatic Cancer Trial (S-1)

Completed
Has Results
  • Locally Advanced or Metastatic Pancreatic Cancer
  • (no location specified)
Nov 9, 2021

Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 6, 2023

Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine 1000 mg, Docetaxel 37.5g
  • Zagreb, Croatia
    University Hospital Centre Zagreb
Jan 20, 2023

Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

Not yet recruiting
  • Lung Adenocarcinoma
  • +3 more
  • Serplulimab and Bevacizumab injection
  • (no location specified)
Dec 21, 2022

Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)

Completed
Has Results
  • Lymphoma, T-Cell
  • Lymphoma, Extranodal NK-T-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Jinan, China
  • +2 more
Sep 10, 2023

Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • IP chemotherapy
  • IP chemotherapy plus simvastatin
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center , Korea
Apr 4, 2022

Pancreatic Cancer, Chemo Effect Trial in Seoul (Gemcitabine, Nab-paclitaxel, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • Chemotherapy Effect
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 15, 2021

Prostate Cancer Trial in Riga (ODM-201 Tablet A, ODM-201 Tablet B, ODM-201 capsule formulation)

Completed
  • Prostate Cancer
  • ODM-201 Tablet A
  • +2 more
  • Riga, Latvia
    P. Stradina Clinical University Hospital
Mar 16, 2021

Patients With Advanced Treatment Naive LCNEC Trial in Tel Aviv (Durvalumab)

Recruiting
  • Patients With Advanced Treatment Naive LCNEC
  • Tel Aviv, Israel
    Assuta MC
Feb 20, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan

Withdrawn
  • Metastatic Ewing Sarcoma
  • Recurrent Ewing Sarcoma
  • Fine-Needle Aspiration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 18, 2022

Gastric Cancer Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, Ipilimumab, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Kashiwa-shi, Chiba, Japan
  • +56 more
Jun 1, 2022

Carcinoma, Small Cell Trial in Hwasun (Belotecan, Etoposide, Cisplatin)

Completed
  • Carcinoma, Small Cell
  • Hwasun, Korea, Republic of
    Chonnam National University Hwasun Hospital
Aug 2, 2021

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,

Active, not recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • Duarte, California
  • +26 more
Aug 3, 2022